Exelixis Inc (EXEL)

Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell

$34.00

Buy

$35.12

arrow-down$-0.60 (-1.71%)

Prices updated at 16 Nov 2024, 00:28 EST
| Prices minimum 15 mins delay
|
Prices in USD
Exelixis Inc is a biotechnology company. It is involved in discovery, development, and commercialization of new medicines for people with cancer. The Cabometyx product generates maximum revenue for the company.
NASDAQ
arrow-down-2.24%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
$35.14 - $34.06
$36.60 - $19.20
-
7,405.13m
22.23
-
2,867,787
4.32
2,193,011.20
0.52
302.79m
US30161Q1040
1.55
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2024 Morningstar. All rights reserved.